Efficacy and Safety of the Treatment of Chronic Hepatitis C with Sofosbuvir/Ledipasvir in Children Aged 5 to 10 Years with Comorbidities—A Brief Report

The efficacy and safety of 12 weeks of therapy with sofosbuvir/ledipasvir in three patients aged 5–10 years are presented. All three children suffered from comorbidities, including chronic kidney disease in two. All participants achieved a sustained virologic response 12 weeks after the end of treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pokorska-Śpiewak, Maria, Dobrzeniecka, Anna, Ogrodnik, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407716/
https://www.ncbi.nlm.nih.gov/pubmed/36005263
http://dx.doi.org/10.3390/idr14040061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407716/
https://www.ncbi.nlm.nih.gov/pubmed/36005263
http://dx.doi.org/10.3390/idr14040061

Ejemplares similares